News on research and diagnostics for metabolic disorders and metabolic diseases.
The collaboration aims to eliminate barriers to testing for chronic kidney disease by standardizing the method for testing for the condition, thereby improving the comparison of test results between labs.
The funding will support further development of an existing serum-based assay and expansion of the test to use saliva samples.
The firm, which specializes in neurogenetics, recently launched several diagnostic RNA sequencing tests and is working on a methylome test for imprinting disorders.
In a study of genetic variants associated with glycated hemoglobin in a meta-analysis, researchers found a G6PD variant leading to deceptively low blood sugar levels.
The new company will develop microbiome diagnostics for multiple indications including inflammatory bowel disease and liver disorders.
